業績

Fujieda Y, Atsumi T. Has lupus anticoagulant testing had its day? Nat Rev Rheumatol. 2019 Jun;15(6):324-325. (PMID: 31000789)

Oku K, Atsumi T. Rheumatology practice in Japan: challenges and opportunities. Rheumatol Int. 2019 Mar 19.PMID: 30888472

Fumihiko Hattanda, Daigo Nakazawa, Kanako Watanabe-Kusunoki, Yoshihiro Kusunoki, Haruki Shida, Sakiko Masuda, Saori Nishio, Utano Tomaru, Tatsuya Atsumi, and Akihiro Ishizu The presence of anti-neutrophil extracellular trap antibody in patients with microscopic polyangiitis Rheumatology, in press.（PMID: 30897615）

Kanako Watanabe-Kusunoki*, Nobuya Abe*, Daigo Nakazawa, Kohei Karino, Fumihiko Hattanda, Yuichiro Fujieda, Saori Nishio, Shinsuke Yasuda, Akihiro Ishizu, Tatsuya Atsumi. Dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced antineutrophil cytoplasmic antibody–associated vasculitis Medicine (Baltimore). 2019 Apr;98(17):e15328. PMID: 31027105

Abe N, Kato M, Fujieda Y, Narita H, Tha KK, Atsumi T. Tumour necrosis factor alpha blockade for non-inflammatory pain: beyond inflammation? Scand J Rheumatol. 2019 May 28:1-3.（PMID: 31135248）

Abe N, Fujieda Y, Amengual O, Atsumi T. Disseminated subcutaneous nodules and destructive polyarthritis. BMJ. 2019 Apr 17;365:l1344. (PMID:30996027）

Noguchi A, *Yasuda S, Hisada R, Kato M, Oku K, Bohgaki T, Suzuki M, Matsumoto Y, Atsumi T. Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: A pilot study. Mod Rheumatol. in press　（PMID: 30789096）

Shen L, Azmi NU, Tan XW, Yasuda S, Wahyuningsih AT, Inagaki J, Kobayashi K, Ando E, Sasaki T, Matsuure E. Mutants of b2-glycoprotein I: Their features and potent applications. Best Pract Res Clin Rheumatol.(PMID:未）

Hiroshi Nomoto, Hiraku Kameda, Akinobu Nakamura, Kazuhisa Tsuchida, So Nagai, Tatsuya Atsumi, Hideaki Miyoshi Breakdown of autonomously functioning thyroid nodule accompanied by acromegaly after octreotide treatment Frontiers in Endocrinology, in press.(PMID: 30881346)

Shibayama Y, Kameda H, Ota S, Tsuchida K, Cho KY, Nakamura A, Miyoshi H, Atsumi T. A case of fulminant type 1 diabetes induced by the anti-programmed death-ligand 1 antibody, avelumab. J Diabetes Investig. 2019 (PMID: 30738003)